New Momentum for Pharmaceutical Development in Central Asia

ACIR Southern Europe continues to strengthen its activities across Central Asia, developing new opportunities for cooperation between European companies and regional partners.

As part of this work, one of the region’s leading companies in pharmaceutical distribution and direct sales has expressed interest in exploring, together with ACIR, new opportunities for cooperation, financing and market expansion for European pharmaceutical producers.

The areas of interest include dermatology, women’s health, cardiology, endocrinology and other therapeutic fields. This growing interest demonstrates the potential available to European companies seeking to establish and develop sustainable commercial activities across Central Asian markets.

The negotiations are based on the benefits and instruments that ACIR makes available to its partners in the region. These range from financial instruments provided by international institutions to support mechanisms and programmes offered by institutional organisations in the countries concerned.

A strategic bridge

ACIR Southern Europe acts as a strategic partner and bridge between Europe and Central Asia, facilitating business dialogue, identifying opportunities and helping structure projects designed to support sustainable, long-term commercial development.